Menu
Enrolling by invitation NCT03503240

Patient Satisfaction With Appearance, Scar Outcome and Quality of Life After Skin Cancer Surgery

Observational Skin Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Skin Cancer. Basic parameters: from 21 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The purpose of this study is to evaluate patient satisfaction and quality of life as it relates to skin cancer surgery. This research study involves taking a one-time survey online.

Primary outcome measures

  • number of patients satisfied with facial appearance [Time frame: 1 year]
  • number of patients satisfied with scar outcome [Time frame: 1year]

Eligibility criteria

Inclusion criteria

  • Patients ≥ 18 years of age at the time of surgery.
  • Had a diagnosis of a cutaneous malignancy
  • Cutaneous malignancy includes, but is not limited to basal cell carcinoma, squamous cell carcinoma, and melanoma
  • Able to speak and read English
  • MSK Only Cross Sectional Study: Radiation therapy patients ≥ 18 years of age who have received RT for skin cancer

Exclusion criteria

  • Unable to speak and read English

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-crossover

Study locations

United States · 5 centers
  • UC Davis Comprehensive Cancer Center — Sacramento
  • Brigham and Women's Hospital (Data Collection Only) — Boston
  • University of Nebraska Medical Center — Omaha
  • Memorial Sloan Kettering Cancer Center — New York
  • University of Texas Southwestern Medical Center at Dallas — Dallas

Identifiers

NCT: NCT03503240 · 18-168

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗